Antibodies derived from natural human immunity Broad range of candidate therapies. Contact Now

Antibody-drug conjugates (ADCs, investigational) Solid tumor and eye disease therapies in development. Contact Now

OncoResponse antibodies (investigational) Derived from cancer survivors’ immune systems. Contact Now

Elotuzumab (Empliciti) Multiple myeloma therapy. Contact Now

Ipilimumab (Yervoy) Immunotherapy for various cancers. Contact Now

Rituximab (Rituxan, MabThera) Non-Hodgkin lymphoma and autoimmune diseases. Contact Now

Panitumumab (Vectibix) Metastatic colorectal cancer therapy. Contact Now

Trastuzumab (Herceptin) Targets HER2 in breast cancer. Contact Now

Bevacizumab (Avastin) Treats cancers including colorectal cancer. Contact Now

Padcev (Enfortumab Vedotin) Urothelial cancer therapy. Contact Now